HLA-C and neoplasm: Other forms of adoptive immunotherapies [71] include T-cell receptor (TCR) therapy and tumor-infiltrating lymphocytes (TIL) therapy which require MHC molecule activation, but CAR-T cells can be activated independently [72, 73].